Skip to Content

RotaTeq (rotavirus vaccine) Disease Interactions

There are 2 disease interactions with RotaTeq (rotavirus vaccine):

Major

Rotavirus Vaccine (Includes RotaTeq) ↔ Immunodeficiency

Severe Potential Hazard, Moderate plausibility

Applies to: Immunodeficiency, HIV Infection, Bone Marrow Depression/Low Blood Counts, Lymphoma

The safety and efficacy of rotavirus vaccine in infants with known primary or secondary immunodeficiencies, including HIV, infants in immunosuppressant therapy, or infants with malignant neoplasm affecting the bone marrow or lymphatic system has not been established. Caution is advised when considering wether to administer this vaccine to such patients or patients with immunodeficient close contacts as there is a potential of transmission of the virus through shedding in stools after vaccination (peak excretion occurring around day 7 after first dose).

Moderate

Rotavirus Vaccine (Includes RotaTeq) ↔ Gi Disorders

Moderate Potential Hazard, Moderate plausibility

Applies to: Diarrhea, Vomiting, Infectious Diarrhea/Enterocolitis/Gastroenteritis

The administration of the rotavirus vaccine should be delayed in infants suffering from acute diarrhea or vomiting. Additionally, the effectiveness of this vaccine has not been evaluated in infants with chronic gastrointestinal disorders.

RotaTeq (rotavirus vaccine) drug Interactions

There are 199 drug interactions with RotaTeq (rotavirus vaccine)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide